2026 Drug Cost Guide: Keytruda, Wegovy, Mounjaro, Zepbound, Opdivo & Imfinzi Prices

Updated U.S. drug cost data (Keytruda, Wegovy, Mounjaro, Zepbound) — Insurance, savings & 2026 trends.

Showing 1 - 6 of 33 drug pricing articles
Will Zepbound Really Get Cheaper in 2026? What Experts Predict - 2026 Drug Cost Analysis

Will Zepbound Really Get Cheaper in 2026? What Experts Predict

27 views

Wondering if Zepbound will finally become more affordable in 2026? As one of the most discussed weight-loss medications in the U.S., many Americans are hoping for price drops as new competitors and insurance changes emerge. This article explores what experts predict, compares Zepbound’s current and expected costs, and highlights financial assistance programs that could help you save in 2026.

Donanemab Cost in 2026: Alzheimer’s Drug Price, Medicare Coverage & Patient Assistance Options - 2026 Drug Cost Analysis

Donanemab Cost in 2026: Alzheimer’s Drug Price, Medicare Coverage & Patient Assistance Options

24 views

Donanemab (Kisunla), Eli Lilly’s Alzheimer’s therapy, is priced around $32,000 per year in 2024–2025 and may rise slightly by 2026. This guide covers the latest projected prices, Medicare and insurance coverage, out-of-pocket estimates, and patient assistance programs available in the U.S. Compare Donanemab vs Leqembi costs, understand CMS registry requirements, and find financial aid options for Alzheimer’s patients.

How Much Does Leqembi Really Cost in 2026? A Complete Alzheimer’s Drug Price & Medicare Guide - 2026 Drug Cost Analysis

How Much Does Leqembi Really Cost in 2026? A Complete Alzheimer’s Drug Price & Medicare Guide

21 views

As Alzheimer’s treatments evolve, Leqembi (lecanemab) stands out as a breakthrough medication—but it comes with a high price tag. In 2026, costs vary depending on insurance coverage, infusion center fees, and Medicare approval. This updated guide reveals current U.S. Leqembi prices, coverage rules, and ways to reduce out-of-pocket expenses through assistance programs and manufacturer discounts.

Leqembi Cost in the US 2026: Alzheimer’s Drug Price, Insurance Coverage & Latest Medicare Data - 2026 Drug Cost Analysis

Leqembi Cost in the US 2026: Alzheimer’s Drug Price, Insurance Coverage & Latest Medicare Data

29 views

Leqembi (lecanemab) is the first FDA-approved Alzheimer’s treatment that directly targets amyloid-beta buildup — but how much does it really cost in 2026? In this updated U.S. guide, we break down the Leqembi cost per month and per year, analyze insurance and Medicare coverage, and compare it to similar Alzheimer’s drugs like Donanemab. We’ll also explore the latest 2025–2026 clinical data, real-world effectiveness, and the newest coverage decisions from Medicare Part B and private insurers. Whether you’re a caregiver, patient, or health professional, this complete Leqembi price analysis helps you understand what you’ll actually pay — and how to save on treatment costs in 2026.

How Much Does Wegovy Cost Per Month in 2026? Updated U.S. Price Guide & Savings Tips - 2026 Drug Cost Analysis

How Much Does Wegovy Cost Per Month in 2026? Updated U.S. Price Guide & Savings Tips

30 views

Wondering how much Wegovy really costs in 2026? This updated U.S. price guide breaks down the average monthly cost of Wegovy with and without insurance, pharmacy price differences, and the best ways to save through coupons, savings cards, and discount programs.

Ozempic Cost in the US 2026: Insurance Coverage, Monthly Price & Cheapest Pharmacies - 2026 Drug Cost Analysis

Ozempic Cost in the US 2026: Insurance Coverage, Monthly Price & Cheapest Pharmacies

28 views

Ozempic continues to be one of the most in-demand prescription drugs in the United States in 2026, especially among adults managing Type 2 diabetes and those seeking effective weight loss solutions. With prices continuing to rise and insurance coverage remaining complex, understanding the real monthly cost of Ozempic in 2026 can help Americans make smarter financial and health decisions. According to the latest 2026 U.S. pharmacy data, the average out-of-pocket cost for Ozempic without insurance is between $935 and $1,050 per month, depending on the dose and the pharmacy. However, patients with private insurance or Medicare Part D can pay as little as $25 to $100 per month through copay savings or manufacturer assistance programs. Below, you’ll find updated 2026 price comparisons, the best discount programs, and key pharmacy links offering the lowest Ozempic prices in the U.S.

Drug Price FAQs: Keytruda, Wegovy, Mounjaro & More

The average cost of Keytruda without insurance in 2026 is around $10,000 to $13,000 per dose. With insurance, out-of-pocket expenses can be as low as $100 depending on the coverage.

Experts expect Zepbound’s price to drop by 10–15% in 2026 as competition and insurance coverage expand. Savings cards and manufacturer programs are also expected to continue.

Wegovy costs between $25 and $150 per month with most insurance plans in the U.S. Without insurance, the price is around $1,350 monthly.

Top Drug Comparisons 2026: Keytruda, Mounjaro, Wegovy & Zepbound

Keytruda vs Opdivo

Compare the 2026 cost, effectiveness, and insurance coverage of both cancer treatments.

Compare Now

Wegovy vs Zepbound

Find out which weight-loss drug offers the best value and results in 2026.

Read Comparison

Mounjaro Savings 2026

Learn how to get the best savings and discounts for Mounjaro through insurance and cards.

See Savings